Loading...

Henry Schein, Inc.

HS2.DEXETRA
HealthcareMedical - Equipment & Services
$74.06
$0.08(0.11%)

Henry Schein, Inc. (HS2.DE) Stock Overview

Explore Henry Schein, Inc.’s financial performance, market position, analyst ratings, and future outlook.

Revenue Growth
2.71%
2.71%
Profit Growth
$3.11
6.25%
EPS Growth
$3.11
3.14%
Operating Margin
4.90%
0.98%
ROE
11.14%
6.25%
Dividend Yield
0.00%
Analyst Recommendations data is not available for HS2.DEAnalyst Recommendations details for HS2.DE are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Company Profile

Henry Schein, Inc. engages in the provision of health care products and services to medical, dental, and veterinary office-based practitioners. The company is headquartered in Melville, New York and currently employs 18,000 full-time employees. The firm operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins. The technology and value-added services segment provides software, technology and other value-added services to healthcare practitioners. Its technology group offerings include practice management software systems for dental and medical practitioners. The firm provides its services to dental practitioners and laboratories, and physician practices, as well as government and institutional healthcare clinics.

CEO

Mr. Stanley M. Bergman

Employees

26,000

Headquarters

135 Duryea Rd, Melville, NEW YORK

Founded

2007

Frequently Asked Questions

Meyka LogoMeyka

Meyka is the best Alternative Data platform powered by AI providing research insights for investors

Connect With Us

Legal Disclaimer

The information provided by Meyka AI PTY LTD is for informational and research purposes only and does not constitute financial, investment, or trading advice. Meyka is a research platform, not a financial advisory service. Investing in financial markets involves risks, and past performance does not guarantee future results. Users should conduct their own due diligence, consult with professional financial advisors, and assess their risk tolerance before making investment decisions. Meyka and its operators are not liable for any financial losses incurred from the use of information on this platform. The data provided is derived from publicly available sources and is believed to be reliable but may not always be accurate or up to date. Users should independently verify information and not rely solely on Meyka for financial decisions. By using Meyka, you acknowledge that it does not provide financial advice or recommendations and agree to seek guidance from a qualified financial professional before making any investment decisions.

© 2025 Meyka AI PTY LTD. All rights reserved.